This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Becton Dickinson and Company Limited, The University of North Carolina at Chapel Hill. Active years: 2018.
Company Filing History:
1 out of 5,394 
1 out of 1,325 
Years Active: 2018
Title: Innovations of Dougald Monroe
Introduction
Dougald Monroe is an accomplished inventor based in Carrboro, NC (US). He holds 2 patents that contribute significantly to the field of coagulation detection and control. His work has implications for medical diagnostics and treatment, particularly in managing blood coagulation.
Latest Patents
Monroe's latest patents include "Methods and compositions for detecting coagulation inhibitors." This invention provides a method for identifying coagulation inhibitors in a sample through a series of specific assays. The process involves contacting the sample with various substrates and thrombin, allowing for the identification of substances such as heparin, low molecular weight heparin, rivaroxaban, and dabigatran based on the cleavage of the substrate.
Another notable patent is "Coagulation controlling agents and devices comprising the same." This invention outlines a device and kit designed for controlling coagulation in blood samples. The method combines thrombin with coagulation controlling agents to stabilize or enhance thrombin's activity, which is crucial for effective blood sample management.
Career Highlights
Throughout his career, Dougald Monroe has worked with reputable organizations, including Becton Dickinson and Company Limited and the University of North Carolina at Chapel Hill. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of coagulation.
Collaborations
Monroe has collaborated with notable colleagues such as Jen-Yea Chang and Shabazz Novarra. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Dougald Monroe's contributions to the field of coagulation detection and control through his patents demonstrate his innovative spirit and dedication to improving medical diagnostics. His work continues to influence the way coagulation is managed in clinical settings.